Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program

Robert B. McLafferty, Marc A. Passman, Joseph A. Caprini, Thom W. Rooke, Steven A. Markwell, Joanne M. Lohr, Mark H. Meissner, Bo G. Eklöf, Thomas W. Wakefield, Michael Dalsing

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.

Original languageEnglish
Pages (from-to)394-399
Number of pages6
JournalJournal of Vascular Surgery
Volume48
Issue number2
DOIs
StatePublished - Aug 2008

Fingerprint

Venous Thromboembolism
Quality of Life
Demography
Physicians
Warfarin
Population
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Increasing awareness about venous disease : The American Venous Forum expands the National Venous Screening Program. / McLafferty, Robert B.; Passman, Marc A.; Caprini, Joseph A.; Rooke, Thom W.; Markwell, Steven A.; Lohr, Joanne M.; Meissner, Mark H.; Eklöf, Bo G.; Wakefield, Thomas W.; Dalsing, Michael.

In: Journal of Vascular Surgery, Vol. 48, No. 2, 08.2008, p. 394-399.

Research output: Contribution to journalArticle

McLafferty, RB, Passman, MA, Caprini, JA, Rooke, TW, Markwell, SA, Lohr, JM, Meissner, MH, Eklöf, BG, Wakefield, TW & Dalsing, M 2008, 'Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program', Journal of Vascular Surgery, vol. 48, no. 2, pp. 394-399. https://doi.org/10.1016/j.jvs.2008.03.041
McLafferty, Robert B. ; Passman, Marc A. ; Caprini, Joseph A. ; Rooke, Thom W. ; Markwell, Steven A. ; Lohr, Joanne M. ; Meissner, Mark H. ; Eklöf, Bo G. ; Wakefield, Thomas W. ; Dalsing, Michael. / Increasing awareness about venous disease : The American Venous Forum expands the National Venous Screening Program. In: Journal of Vascular Surgery. 2008 ; Vol. 48, No. 2. pp. 394-399.
@article{5a747a4d840a4dc29a378592406decd3,
title = "Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program",
abstract = "Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77{\%} female; 80{\%} Caucasian; mean BMI of 29 (range, 11-68); 40{\%} current or previous smoker; and 24{\%} taking antiplatelet therapy and 4{\%} taking warfarin. If placed in a situation conducive for VTE, 40{\%} of participants were low risk, 22{\%} were moderate risk, 21{\%} were high risk, and 17{\%} were very high risk. On a venous QOL assessment, 17{\%} had a combined total score for all 11 questions of {"}very limited{"} or {"}impossible to do.{"} Reflux or obstruction was noted in 37{\%} and 5{\%} of participants, respectively. CEAP class 0 to 6 was 29{\%}, 29{\%}, 23{\%}, 10{\%}, 9{\%}, 1.5{\%}, 0.5{\%}, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.",
author = "McLafferty, {Robert B.} and Passman, {Marc A.} and Caprini, {Joseph A.} and Rooke, {Thom W.} and Markwell, {Steven A.} and Lohr, {Joanne M.} and Meissner, {Mark H.} and Ekl{\"o}f, {Bo G.} and Wakefield, {Thomas W.} and Michael Dalsing",
year = "2008",
month = "8",
doi = "10.1016/j.jvs.2008.03.041",
language = "English",
volume = "48",
pages = "394--399",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Increasing awareness about venous disease

T2 - The American Venous Forum expands the National Venous Screening Program

AU - McLafferty, Robert B.

AU - Passman, Marc A.

AU - Caprini, Joseph A.

AU - Rooke, Thom W.

AU - Markwell, Steven A.

AU - Lohr, Joanne M.

AU - Meissner, Mark H.

AU - Eklöf, Bo G.

AU - Wakefield, Thomas W.

AU - Dalsing, Michael

PY - 2008/8

Y1 - 2008/8

N2 - Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.

AB - Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods: Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.

UR - http://www.scopus.com/inward/record.url?scp=47249116467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249116467&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2008.03.041

DO - 10.1016/j.jvs.2008.03.041

M3 - Article

C2 - 18572373

AN - SCOPUS:47249116467

VL - 48

SP - 394

EP - 399

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 2

ER -